🇺🇸 FDA
Pipeline program

ARO-RAGE

ARORAGE-1001

Phase 2 small_molecule active

Quick answer

ARO-RAGE for Asthma is a Phase 2 program (small_molecule) at Arrowhead Pharmaceuticals Ireland Limited with 2 ClinicalTrials.gov record(s).

Program details

Company
Arrowhead Pharmaceuticals Ireland Limited
Indication
Asthma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials